Company: JLL
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001037976-25-000071
Chunk: 111

Company: JONES LANG LASALLE INC
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 8
Chunk 111
---
2025, that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

48

Part II. Other Information

Item 1. Legal Proceedings

We are a defendant or plaintiff in various litigation matters arising in the ordinary course of business, some of which involve claims for damages that are substantial in amount. Many of these litigation matters are covered by insurance, including insurance provided through a captive insurance company, although they may nevertheless be subject to large deductibles and the amounts being claimed may exceed the available insurance. Although we cannot determine the ultimate liability for these matters based upon information currently available, we believe the ultimate resolution of such claims and litigation will not have a material adverse effect on our financial position, results of operations or liquidity.

Item 1A. Risk Factors

There have been no material changes to our risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024. 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about our purchases of equity securities that are registered by us pursuant to Section 12 of the Exchange Act during the quarter ended September 30, 2025.

PeriodTotal number of shares purchasedWeighted average price paid per shareTotal number of shares purchased as part of publicly announced planApproximate dollar value of shares that may yet be purchased under the plan (in millions)July 1, 2025 - July 31, 202538,534 $259.51 38,534 August 1, 2025 - August 31, 2025104,210 $289.12 104,210 September 1, 2025 - September 30, 202596,655 $309.04 96,655 $882.0 Total239,399 239,399 

Item 5. Other InformationDuring the quarter ended September 30, 2025, none of the Company's directors or officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of a Rule 10b5-1(c) trading arrangement or a non-Rule 10b5-1 trading arrangement as such terms are defined under Item 1 408(a) or Regulation S-K.

49

Item 6. Exhibits

Exhibit NumberDescription31.1*Certification of Chief Executive Officer pursuant to